InforMS: Winter 2019

FEATURED ARTICLES

What’s Next? Identifying MS Biomarkers Could Prove a Game-Changer

By Peter Broderick

MORE FROM THIS ISSUE

InforMS: Winter 2019

What’s Next? Identifying MS Biomarkers Could Prove a Game-Changer

By Peter Broderick

Research efforts at the Rocky Mountain MS Center at University of Colorado have been at the forefront of multiple sclerosis care and treatment for decades, but in all those years...

InforMS: Winter 2019

Building Opportunities for Collaboration through Research

By Peter Broderick

The Translational Research Lab has presented the RMMSC at CU with unique opportunities for collaborations with other medical groups, both inside and outside the CU community. “We are collaborating with...

InforMS: Winter 2019

Astrocytes: A New Target for MS Treatment

By Kerri Cechovic

An Interview with Dr. Timothly Vollmer InforMS: Many advancements and research in MS are really leading to neuro-reparative therapy. Can you tell us what’s changed to spur that? Dr. Vollmer: I...

InforMS: Winter 2019

Make a Difference! Support Your MS Team

By Rocky Mountain MS Center

Through care, support, education, and research, the Rocky Mountain MS Center is leading the way in developing effective treatments and therapies. The Rocky Mountain MS Center is a local nonprofit...

InforMS: Winter 2019

‘I Have MS, MS Doesn’t Have Me’

By Kerri Cechovic

Jessica Ahern grew up in Connecticut and moved to Colorado in 2015. She works as a social worker in Jefferson County to help support families and children who are facing...

InforMS: Winter 2019

When the Writing’s On the Wall: What to Do When Your Continued Employment is in Jeopardy

By Thomas Stewart, MS, JD, PA-C

Many people with MS will never become disabled, especially those who receive proper treatment. However, the fact remains: some people with MS will develop symptoms that begin to interfere with...